Search - tctmd.com

Displaying 261 - 280 of 864

Sort: Relevancy | Date

Presentation THT 2024

Deep Phenotyping in Cardiogenic Shock

Presenter: Song Li

March 05, 2024

Presentation THT 2024

Risk Stratification: Thinking Beyond SCAI Staging

Presenter: David A. Baran

March 05, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Presentation THT 2024

Innovations in Management of ECMO-Supported Patients

Presenter: E Wilson Grandin

March 05, 2024

Presentation THT 2024

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Presenter: Debapria Das

March 05, 2024

Presentation THT 2024

Innovations for RV Support in Shock

Presenter: Jaime Hernandez Montfort

March 05, 2024

Presentation THT 2024

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Presenter: José Alfredo Salinas-Casanova

March 05, 2024

Presentation THT 2024

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Presenter: Ehud Schwammenthal

March 05, 2024

Presentation THT 2024

Early Experience With the Supira Microaxial Flow Pump

Presenter: Azeem Latib

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Istraoxime for Cardiogenic Shock

Presenter: Gad Cotter

March 05, 2024

Presentation THT 2024

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Presenter: Hidetaka Morita

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Advertisement

Deep Phenotyping in Cardiogenic Shock

Risk Stratification: Thinking Beyond SCAI Staging

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Innovations in Management of ECMO-Supported Patients

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Innovations for RV Support in Shock

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Early Experience With the Supira Microaxial Flow Pump

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Istraoxime for Cardiogenic Shock

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content